ARRAY BIOPHARMA INC 4
4 · ARRAY BIOPHARMA INC · Filed Apr 3, 2012
Insider Transaction Report
Form 4
SNITMAN DAVID
DirectorCOO and VP, Business Devel.
Transactions
- Award
Stock Option (Right to Buy)
2012-03-30+90,000→ 90,000 totalExercise: $3.40Exp: 2022-03-30→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning June 16, 2013.